Amgen Slovakia s.r.o. is the Slovak affiliate of Amgen, a global biotechnology company, with its head office in Bratislava and a primary focus on the distribution and marketing of innovative biologic medicines. Its main business segment is the wholesale of pharmaceuticals, concentrating on advanced biologic therapies and, where applicable, biosimilars in therapeutic areas such as oncology and hematology, nephrology, cardiology and osteoporosis, supplied to hospitals, specialized clinics and pharmacies through national wholesaler and hospital tender channels. The company also performs medical, regulatory and pharmacovigilance activities to support Amgen's portfolio in Slovakia and contributes to scientific communication and continuing medical education for healthcare professionals. Geographically, Amgen Slovakia serves the entire Slovak market while being closely integrated into Amgen's European network, benefiting from shared regional structures in medical affairs, clinical trials and market access. It operates under the Amgen corporate brand, leveraging the group's global reputation in biotechnology, its proprietary biologic molecules and platform technologies, and its long established relationships with key opinion leaders and medical institutions as core assets. Strategically, Amgen Slovakia focuses on introducing and expanding access to innovative biologic therapies for patients with serious and chronic diseases, supporting participation of Slovak patients and centers in international clinical studies, and building long term partnerships with stakeholders in the healthcare system on the basis of high scientific standards, strict regulatory compliance and a focus on patient outcomes.
Headquarters
Bottova, 2A
Bratislava; Bratislavsky;
Postal Code: 81109
Contact Details: Purchase the Amgen Slovakia S.R.O. report to view the information.
Website: https://www.amgen.sk
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service